SCHEMBL6412386

SCHEMBL6412386

CCCC[Sn](CCCC)(CCCC)c1nc2ccccc2s1.[Li]CCCC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.43
RAB9A P51151 8/20 0.43
ALDH1A1 P00352 4/20 0.43
FBP1 P09467 2/20 0.41
SMN1; SMN2 Q16637 5/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CYP1A2 P05177 2/20 0.39
CYP2C19 P33261 2/20 0.39
NFKB1 P19838 1/20 0.39
STAT1 P42224 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
KDM4E B2RXH2 2/20 0.38
ALOX15 P16050 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
ADRA2A P08913 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
DRD2 P14416 1/20 0.38
HPGD P15428 1/20 0.38
ADRA2B P18089 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL226631 0.93 FBP1 (0.46) NPC1RAB9AALDH1A1FBP1SMN1; SMN2
SCHEMBL5953086 0.68 ALDH1A1 (0.48) NPC1RAB9AALDH1A1FBP1SMN1; SMN2
2-Mercaptobenzothiazole SCHEMBL28518526 0.66 NPC1 (0.47) NPC1RAB9AALDH1A1FBP1SMN1; SMN2
SCHEMBL2034241 0.66 SMN1; SMN2 (0.62) NPC1RAB9ASMN1; SMN2L3MBTL1CYP1A2
SCHEMBL6410067 0.66 FBP1 (0.38) FBP1L3MBTL1PDK1
SCHEMBL578124 0.65 NOS1 (0.34) ALDH1A1GAA
SCHEMBL175532 0.65 ALOX15 (0.60) RAB9AALDH1A1SMN1; SMN2L3MBTL1CYP1A2
Benzene SCHEMBL28273759 0.65 SMN1; SMN2 (0.65) NPC1RAB9ASMN1; SMN2L3MBTL1CYP1A2
SCHEMBL31173766 0.65 ALOX15 (0.60) RAB9AALDH1A1SMN1; SMN2L3MBTL1CYP1A2
SCHEMBL11428596 0.65 NPC1 (0.53) NPC1RAB9AALDH1A1FBP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1499616-A1 HETEROCYCLIC COMPOUNDS AstraZeneca AB (SE) 2005-01-26 EP disclosed
WO-2003087104-A1 HETEROCYCLIC COMPOUNDS ASTRAZENECA AB (SE) 2003-10-23 WO disclosed